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Abstract
Background: The Patient Activation Measure (PAM13) is an instrument that assesses patient knowledge, skills, and
confidence for disease self-management. This cross-sectional study was aimed to validate a culturally-adapted
Italian Patient Activation Measure (PAM13-I) for patients with chronic conditions.
Methods: 519 chronic patients were involved in the Italian validation study and responded to PAM13-I. The PAM
13 was translated into Italian by a standardized forward-backward translation. Data quality was assessed by mean,
median, item response, missing values, floor and ceiling effects, internal consistency (Cronbach's alpha and average
inter-item correlation), item-rest correlations. Rasch Model and differential item functioning assessed scale
properties.
Results: Mean PAM13-I score was 66.2. Rasch analysis showed that the PAM13-I is a good measure of patient
activation. The level of internal consistency was good (α = 0.88). For all items, the distribution of answers was
left-skewed, with a small floor effect (range 1.7–4.5 %) and a moderate ceiling effect (range 27.6–55.0 %). The Italian
version formed a unidimensional, probabilistic Guttman-like scale explaining 41 % of the variance.
Conclusion: The PAM13-I has been demonstrated to be a valid and reliable measure of patient activation and the
present study suggests its applicability to the Italian-speaking chronic patient population. The measure has good
psychometric properties and appears to be consistent with the developmental nature of the patient activation
phenomenon, although it presents a different ranking order of the items comparing to the American version.
PAM13-I can be a useful assessment tool to evaluate interventions aimed at improving patient engagement in
healthcare and to train doctors in attuning their communication to the level of patients’ activation. Future research
could be conducted to further confirm the validity of the PAM13-I.
Background
Western healthcare systems are still geared toward acute
care [1] and are not well equipped to handle the long-
term commitment required to treat chronic conditions.
Patients themselves and their families are a crucial re-
source to the long-term management of chronic condi-
tions, as they can actively contribute to shape the care
process in order to make it more and more aligned to
their expectations [2–7]. Optimal treatment of chronic
illnesses requires not only a healthcare system that rec-
ognizes the patient as central to his or her care; it also
requires an activated patient who knows what to do (in
terms of health management behaviors and who has the
skills and motivation to do so (in terms of attitudes and
knowledge). Many researchers [8–10] have found that
engaged, informed, confident, and skilled patients are
more likely to perform activities that will ensure their
own health. Moreover, active patient engagement in
healthcare has been also demonstrated to lower health-
care costs [11].
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To successfully engage patients in their healthcare, it
is fundamental to deeply understand their subjective ill-
ness experience and attitudes when navigating health-
care. An experience that is complex at the psychosocial
level and that develops in time, according to the features
of the patient’s illness journey [12–15]. Tools able to as-
sess and targeting the level of activation and engagement
of patients in their health management are crucial, al-
though they are still underdeveloped and scarcely used
[16]. According to Hibbard and colleagues [17], patient
activation is defined as having “the knowledge, skills, con-
fidence and behaviors needed for managing one's own
health and health care”. Patient activation describes the
level of patients’ engagement in their healthcare and, ac-
cording to many outcome studies in this field, it leads to
better disease self-management [18, 19], higher adher-
ence to medical treatment and greater patient satisfac-
tion [17, 20]. Patients on a higher activation level more
often engage in healthy behaviors, more actively cope
with their illness, make more efficient use of healthcare
services and perform better self-care [21]. Cross-
sectional studies have demonstrated that chronically ill
and primary care patients who are more actively in-
volved in their care not only have better self-reported
health outcomes [19], but also better clinical outcomes
[22, 23]. The American Patient Activation Measure short
form (PAM 13) [17] consists of 13 items measuring pa-
tients’ self-reported knowledge, motivation, and skills for
self-management (see Appendix 1). It was developed
using a Rasch model [18] and it has been validated in
the US general population and, more recently, in other
countries – such as Germany [24], Netherlands [25],
Denmark [26] Israel [27], Norway [28], and Korea [29] –
across different clinical settings [22, 23, 30–32].
Italian policy makers and public health researchers
are more and more interested in strategies to effect-
ively make chronic patients actively engaged in their
healthcare [13, 14, 33–35]. In Italy, according to the
European statistics, this clinical population is growing
in numbers and is more and more gaining attention
due to its potential social and economic impact [21].
For these reasons, there is definitely a clinical and
scientific need for a validated assessment tool that
can help practitioners differentiate patients into sub-
groups that require different strategies in health sup-
port, information and communication. Therefore, the
present research project was conducted in Italy in
order to:
 translate the American short form Patient
Activation Measure (PAM 13) into an Italian
version (PAM13-I);
 establish the psychometric properties of the Italian
version of the PAM 13; and
 validate the Italian version of the American PAM 13
in a sample of chronically ill patients.
Methods
Recruitment and data collection
This cross-sectional study included a simple random
sample of 529 Italian-speaking adults affected by differ-
ent chronic conditions. Patients were randomly selected
and recruited through the online panel provided by Re-
search Now (http://www.researchnow.com/en-US.aspx),
a professional research institute with branches across
the world. The panel covers a wide range of chronic
conditions and counts more than 6.5 million registered
subjects worldwide. Subjects belonging to the panel are
carefully screened for authenticity and legitimacy via
digital fingerprint and geo-IP-validation from the pro-
vider. Panel recruitment and data collection processes
are compliant with national laws in each country where
Research Now operates. All panelists are profiled on the
basis of their socio-demographic, clinical and life-styles
characteristics. The panel is certified to be statistically
representative of all the covered populations. In our
study, in order to guarantee data quality, respondents
were asked to confirm their demographics (i.e. sex, date
and place of birth, ethnicity, nationality, educational
level, place of residency) and clinical condition (i.e.
health status, chronic diagnosis, date of first diagnosis,
prescribed medications) previously collected by the Re-
search Now Panel. To be included in our study, patients
had to be Italian, affected by one or more chronic condi-
tions, aged over 18 years old, and of both genders. Pa-
tients with dementia, cognitive impairments, active
psychiatric disorders, blindness, deafness, or insufficient
Italian language skills to meaningfully answer to the
questions or without informed consent were excluded
from this study. All participants gave written informed
consent before being enrolled in the study. Patients
completed the PAM13-I questionnaire between October
and December 2014. Ethic approval was obtained from
the Ethics Committee of the Università Cattolica del
Sacro Cuore, Milan (Italy).
Translation and cultural adaptation of the American
PAM 13
After receiving permission from Insignia Health, Inc.,
PAM 13 - the American original version - [17] was
translated as recommended by the World Health Orga-
nization’s procedures for cross-cultural validation and
adaptation of self-report measures [36]. This method in-
cludes the following steps: forward translation, experts’
qualitative interviews, backward translation, pilot testing
on patients (for checking the readability and understand-
ing of items) and consensus about the final version (see
Appendix 2). The forward and backward translation
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were performed by professionals who were familiar with
the lexicon of the field, knowledgeable in both English and
Italian cultures. A bilingual expert panel, composed by
twelve individuals (experts in chronic care, health re-
searchers, clinicians and translators), was convened to
identify and resolve ambiguous expressions or concepts
that could lead to misunderstanding. Discrepancies were
discussed, consensus was achieved, and the cultural ap-
propriateness of the translation was confirmed. Finally, a
pilot testing of the scale was performed on fifteen chronic
patients to investigate their understanding of the items
and cognitive equivalence of the translation, followed by
debriefing. PAM13-I was judged clear and acceptable and
the final version was created by consensus.
Measures
PAM13-I
PAM13-I consists of 13 items on a Likert scale. Accord-
ing to the American version of PAM 13, each item has
five response categories with scores from 1 to 5: (1)
“Strongly Disagree”, (2) “Disagree”, (3) “Agree”, (4)
“Strongly Agree” and (5) “Not Applicable”. The instru-
ment design reflects the four stages of activation in a
progressing difficulty of the items: level 1 (patients be-
lieve that their role is important: item 1 and 2), level 2
(patients have confidence and knowledge to take action:
items 3–8), level 3 (taking action: items 9–11) and level
4 (staying on course under stress: items 12 and 13). Ac-
cording to Insigna Health Inc. guidelines, the raw scores
were transformed through natural logarithm to achieve a
better expression of the relative distance between the
scores. Then, items were transformed to a standardized
metric ranging from 0 to 100 (0 = lower activation; 100 =
highest activation), to compare Italian results to the
original data. The score was calculated by summing
up the raw scores and mapping up the sum onto a
scale of 0–100. A higher score of PAM13-I indicates
a high level of patient activation.
Other measures
Age, gender, chronical disease (Asthma, Celiachia,
Hypertension, Chronic Obstructive Pulmonary Disorder,
Diabetes, Cardiovascular Disorder, Cancer, Chron, Fibro-
mialgy, Coliteulcerosa, Lupus, Osteoatritis, Artritereu-
matoide, Hypercolesterolemia, Epatitis, Anemy, Allergy),
marital status (divorced, married, single, widow, and
widower), education (graduated, high school, middle
school, and primary school), profession (employee, free-
lancer, student, retired, unemployed) and children (yes
or no) were used as background variables.
Data analysis
According to COSMIN checklist [37] and to previous
PAM 13 validation studies [24, 26], the statistical
analysis was conducted in three main steps: missing data
analysis, reliability analysis, and Rasch Model analysis.
The first phase regarded the data quality analysis. Ac-
cording to other validation studies [24, 25], participant
who filled out less than 7 items on the PAM13-I ques-
tionnaire were excluded from validation study. Data
were described for each item with frequencies and
percentage of missing responses, response options
(“Strongly Disagree”, “Disagree”, “Agree”, “Strongly
Agree”, “Not Applicable”) and with several statistical in-
dices (mean, median, standard deviation). An evaluation
of floor and ceiling effects was also performed.
The second step regarded the reliability analysis. In-
ternal consistency and reliability analysis were assessed
using Cronbach’s α as well as item-rest correlation,
inter-item correlation, average inter-item correlation.
Cronbach’s α of 0.80 was defined as acceptable [38].
Item-rest correlation provided empirical evidence that
each item was measuring the same construct measured
by the other items included. A correlation value more
than 0.3 indicates a moderate and valid correlation with
the scale overall and, thus, the item should be not re-
moved [39]. Average inter-item correlation is a subtype
of internal consistency reliability, obtained by taking all
of the items on a test that test the same construct, deter-
mining the correlation coefficient for each pair of items,
and finally taking the average of all of these correlation
coefficients. This final step yields the average inter-item
correlation. An average inter-item correlation between
0.15-0.50 was considered acceptable [38].
In the third step, a Rasch Model (RM) was imple-
mented to examine the PAM13-I psychometric proper-
ties. RM is useful to investigate unidimensionality of the
construct (fundamental requisite of the summarization
of the raw scores), the fit and the reliability of each item,
and the differential item functioning.
The Rasch model assumes that the responses are af-
fected by two different components that work independ-
ently [40]. The first component concerns the individual
characteristics of the subjects and the other to the “dis-
placement” of the generic item gathering the latent as-
pect of interest. The classical approach of RM [41]
assumes that the response probability of each subject to
a generic item depends on the level of the latent aspect
(ability) and on the difficulty of the item. RM belongs to
the family of IRT measurement models, which scale raw
observed scores into linear reproducible measurements.
Under the hypotheses that there are two different as-
pects (linked to subjects and items), acting in a separable
manner, RM allows for constructing a single metric scale
defining a ranking of Items and Person parameters. RM
is designed to estimate the subject’s level on the latent
trait, net of item characteristics, and items’ net of sub-
jects. Let pijk be the probability that unit i, with person
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parameter θi, chooses the category k for evaluating the
item j; it may be represented through a proper “link
function” φ (θi,βj) in the parameters θi and βj, account-
ing, respectively, for personal and item characteristics.
RM assumes the last relation to be of the logistic type.
In the family of the polytomous models, we consider the
Partial Credit Model (PCM) to our sample to examine
model-data fit. PCM was chosen because the PAM13-I
items had more than two response options and they
showed different pattern of usage. Since it is reasonable
to assume that the thresholds are not the same for all
the items, i.e., each item has its own unique rating scale
structure, the PCM appears the most appropriate model.
The parameters of the model are estimated by the max-
imum likelihood method [41]. We performed PCA - part
of PCA on Rasch residuals - in order to test the unidi-
mensionality of the construct under investigation.
In the context of patient activation measure analysis,
the parameters θi and βj have a specific interpretation.
The individual characteristic θi, usually called “ability”,
may be conceived as the individual activation: subjects
with higher score in this subscale (Personal Location)
will have a higher level of activation. The item character-
istic βj, called “item difficulty” in the classical Rasch ex-
ample, in this context represents the item propensity to
obtain, by the respondents, systematically high or low
scores when measuring the latent trait of interest. They
reflect the level of relevance for a particular aspect mea-
sured by each item of the survey. In this way, it is pos-
sible to order the survey’s items basing on their different
tendency in arousing the activation.
Unidimensionality of items composing PAM13-I was
examined, using a Principal Component Analysis (PCA).
The aim is to obtain one common factor that explains at
least 30–40 % of the total variance. The other funda-
mental condition is that there are no other factors hav-
ing eigenvalues greater than 3 [42]. Bartlett’s test of
sphericity was performed to explore the factorability of
the correlation matrix and Kaiser-Mayer-Olkin Index
was calculated as a measure of sampling adequacy.
Local Independence of item was tested by a PCA con-
ducted on the Rasch item measure residuals, in order to
analyze the amount of unexplained variance and whether
this unexplained variance indicates that there may be
more than one dimension. Generally, Rasch-conforming
data produces residual-factors with eigenvalues up to 2.0
[43]. Thus, if there is more than one contrast (factors) in
the residuals, there may be a second dimension. Con-
trasts in the Rasch analysis of residuals contradict
unidimensionality.
Two item fit mean square (MNSQ) statistics (infit and
outfit) were computed to check whether the items fitted
the expected model. MNSQ determines how well each
item contributes to defining a single underlying
construct. Infit is more sensitive to misfitting responses
to items closest to the person's ability level, while outfit
is more sensitive to misfitting items that are farther
away. If the data fit the Rasch model, the fit statistics
should be between 0.6 and 1.4. According [44], for clin-
ical observations, the fit statistics could be between 0.5
and 1.5 [26].
The person separation index (PSI) is indicators of
quality of measures. The PSI refers to the reproducibility
of the measure location of the persons. A separation
index, in its normalized form, of 0.80 or higher is con-
sidered reliable.
Differential Item functioning (DIF) was assessed in
order to verify no relevant differences in the probability
to endorse a certain item for subgroups, determined by
gender, age and education. The scale should work irre-
spective of the group considered. Andersen’s Likelihood
Ratio Test was performed for each item. To evaluate
floor and ceiling effects we evaluated for each item the
percentage incidence respectively of the lower level of
the scale (Strongly Disagree) and of the upper one
(Strongly Agree). Analyses were conducted with IBM
SPSS 21.0 and R 3.0.3 (package eRm).
Results
Translation and adaptation
During the translation and forward translation process,
we recognized few general problems when comparing
the Italian version with the American one [17]. As in the
forward-translation, we had difficulty translating health
service terminology, partly because of organizational dif-
ferences, and partly because of a lack of specific Italian
words for “healthcare”, “illness” and “disease”. The in-
strument pre-testing administered to patients in a pre-
liminary phase of the study, allowed understanding that
some terms - i.e. “health” and “disease”- might have differ-
ent meanings and conceptualizations for Italian patients.
For example, in item 2, the American form of PAM 13
uses the terms “health” and “ability to function”, referring
to the capability of a patient to reach positive outcomes by
having an active role in his health management. According
to the results of the translation process, researchers de-
cided to use “benessere” [= “wellbeing” instead of “health”]
and “qualità di vita” [= “quality of life” instead of “ability
to function”] in the final PAM13-I. This change in transla-
tion is a consequence of the fact that, for the Italian pa-
tients, “health” means a general state of wellbeing that is
not a mere absence of an illness condition. Another case
of linguistic adaptation occurs in item 9, where “health”
was traduced with “disease” [= malattia]. The reason be-
hind this linguistic choice was that, referring to a medical
treatment, Italian subject are more akin to think about a
clinical condition, and thus referring to “disease”.
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Study Population
Among 600 individuals who were contacted, 529 partici-
pants completed the survey (redemption rate: 88 %),
which elicited socio-demographic and clinical data, in-
cluding the PAM13-I scale. Participant who filled out
less than 7 items on the PAM-I questionnaire were
excluded from validation study. According to inclusion/
exclusion criteria, the final sample suitable for the study
included 519 patients. The main socio-demographic
characteristics of the sample included in the study are
described in Table 1.
Patients aged from 20 to 90 (M = 53.0, SD = 17.1).
Gender was equally distributed (49.1 % male, 50.9 % fe-
male), with different educational levels. Regarding health
characteristics, patients reported having at least one of
chronic disease. The most common clinical conditions
were asthma (16.4 %), hypertension (20.2 %), diabetes
(16.2 %), cardiovascular disorder (29.1 %), cancer
(21.0 %), and allergy (16.6 %). The majority of the pa-
tients included in our sample was affected by more than
one chronic condition.
Description of the PAM13-I
Table 1 shows the mean PAM13-I scores. Raw scores
range from 13–52. These are converted to “activation
scores” ranging from 0–100 [45], which can be analyzed
as a continuous variable. Higher scores indicate increas-
ing patient activation.
In the Italian sample, male patients had a slightly
higher level of activation, but this difference was not sig-
nificant (p = 0.14). Moreover, no significant differences
were found in the mean PAM13-I score based on educa-
tion (p = 0.10), although PAM13-I score increased in
relation with educational level. Concerning the partici-
pant’s age the sample was clustered in three age groups
(<45 years old, 45–64 years old, > 65 years old). With
increasing age, the level of activation significantly de-
creased (p = 0.02). For this factor (diagnosis), a test was
not conducted, since almost all the participants had
more than one disease and, consequently, the groups
were not independent.
Validation study
Psychometric properties
To evaluate the psychometric properties of the PAM13-
I, data quality, internal consistency, reliability, item-rest
correlation, item-total correlation and average inter-item
correlation were assessed. Table 2 describes the psycho-
metric features of the 13 items included in the PAM13-I.
Percentage of missing values per item was low and it
ranged between 0.8 % (items 1, 3, 5, 13) and 2.1 % (item 8),
as well as percentage of “Not Applicable” (ranging between
0.4 % and 2.6 %).
For all items, the distribution of answers was left-
skewed, with a small floor effect (range 1.7–4.5 %) and a
moderate ceiling effect (range 27.6–55.0 %).
The frequencies of the response categories showed lit-
tle use of the category “Strongly Disagree” and a moder-
ate frequency for “Disagree”. The categories “Agree” and
“Strongly Agree” were used with the highest frequency
for all the items.
The median score was 4 for items 1, 2 and 7, while
for all the other items the median score was equal to
3. The mean scores ranged from 2.99 (item 12) to
3.42 (item 2). Standard deviations showed a constant
Table 1 Mean PAM13-I scores by socio-demographic and
health characteristics
Characteristics Total N % PAM 13
Score Mean
P-value
Total 519 100 66.2
Sex 0.14
Male 255 49.1 67.3
Female 264 50.9 65.1
Age Group 0.02
<45 170 32.8 68.1
45–64 212 40.8 66.8
>65 137 26.4 62.9
Education 0.10
Primary school 81 15.6 63.3
Middle school 88 17.0 64.6
High school 226 43.5 66.5
Graduate or higher 124 23.9 68.8
Diagnosis -
Asthma 85 16.4 64.3
Celiachia 13 2.5 74.9
Hypertension 105 20.2 66.3
Chronic Obstructive
Pulmonary Disorder
21 4.0 61.5
Diabetes 84 16.2 66.5
Cardiovascular_Disorder 151 29.1 68.2
Oncology 109 21.0 65.1
Chron 9 1.7 64.5
Fibromialgy 27 5.2 58.3
Coliteulcerosa 16 3.1 65.8
Lupus 8 1.5 69.6
Osteoatritis 38 7.3 60.6
Artritereumatoide 38 7.3 65.6
Hypercolesterolemia 53 10.2 62.9
Epatitis 11 2.1 62.1
Anemy 15 2.9 71.6
Allergy 86 16.6 68.9
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variability in all items, ranged from 0.72 (items 2, 3)
to 0.82 (item 9).
Generally, the last items have a lower mean score
compared to the earlier items in the questionnaire. How-
ever, in our results the individual item sequence did not
exactly follow the original US scale (from higher to
lower scoring items).
A Cronbach’s alpha equal to 0.88 for the sum scale
and a Person Separation Index of 0.89 were found, and
they were considered as a very good level of internal
consistency. The inter-rest correlations per item to the
sum scale were moderate (for item 1 and 2) to strong
(for all other items) and ranged from 0.36 to 0.66. The
inter-item correlations ranged from 0.16 to 0.56, with
an Average inter-item correlation equal to 0.36. All reli-
ability indices supported the assumption of unidimen-
sionality of the measured construct, and they were
coherent with the results obtained in other validations
of PAM 13 [24, 26, 29].
Rasch analysis
Unidimensionality is fundamental for the Rasch Model.
A PCA on PAM13-I items was conducted with this aim
(Table 3). A total of 41.0 % of the variance was explained
by one factor with an eigenvalue of 5.33. The correlation
matrix had good factorability, Bartlett’s test of sphericity
showed the chi-square was significant at the .0001 level
(Chi-square = 2129.7, df = 78, p < 0.001) and the index of
Kaiser-Mayer-Olkin measure of sampling adequacy was
equal to 0.89.
A PCM was used in order to evaluate the item fit
statistics. The item statistics ranged from 0.76 to 1.22
for the infit MSQ and from 0.74 to 1.32 for the outfit
MSQ. These values indicate a very good fit of the
Rasch Model. The distances between subsequent
thresholds showed sufficient distinction between the
response options and measurement model fit and
none thresholds exceeded the limit of 4.0 logit. Only
items 7 and 10 presented a minor problem of distinc-
tion between thresholds 1 and 2. In Table 3, the item
difficulty was ranked according to their location pa-
rameters. Results showed that the original ranking of
difficulties established for the original American ver-
sion [17] could not be confirmed for the Italian PAM
13 (the order of the original item corresponds to the
difficulty ranking in the American version). The most
important differences are related to item 5, 6, 9 and
10. The Rasch person-item map shows the person
parameter distribution on the latent underlying di-
mension and the item difficulties (Fig. 1). Persons on
the right side of the scale report being more activated
than persons on the left side. Since the black dot rep-
resents the location parameter, items with the black
dot on the right side of the scale report being more
difficult than items with black dot on the left side.
White dots represent the thresholds values.
PCA of item measure residuals revealed one dimen-
sion. A total of 63.4 % of the variance in the data was
explained by the measures and with a perfect model
fit, this was expected to be 63.1 %. The eigenvalue of
the first PCA contrast was 1.78, which corresponded
to 14 % of the variance in the data, the second was
1.65, which corresponded to 12 % of the variance in
the data. Rasch dimensionality analysis confirmed the
hypothesis of unidimensionality and local independ-
ence of the 13 items.
Table 2 Data description of the Italian version of the PAM13 (PAM 13-I)
PAM13-I
item no.
Missing Values
n (%)
Not Applicable
n (%)
Strongly Disagree
n (%)
Disagree
n (%)
Agree
n (%)
Strongly Agree
n (%)
Median Mean SD Inter-rest
correlation
PAM13-I 1 4 (0.8 %) 2 (0.4 %) 15 (2.8 %) 47 (8.9 %) 170 (32.1 %) 291 (55.0 %) 4 3.41 0.77 0.36
PAM13-I 2 5 (0.9 %) 5 (0.9 %) 9 (1.7 %) 45 (8.5 %) 184 (34.8 %) 281 (53.1 %) 4 3.42 0.72 0.41
PAM13-I 3 4 (0.8 %) 11 (2.1 %) 11 (2.1 %) 48 (9.1 %) 238 (45.0 %) 217 (41.0 %) 3 3.29 0.72 0.53
PAM13-I 4 6 (1.1 %) 12 (2.3 %) 15 (2.8 %) 44 (8.3 %) 209 (39.5 %) 243 (45.9 %) 3 3.33 0.76 0.62
PAM13-I 5 4 (0.8 %) 8 (1.5 %) 15 (2.8 %) 68 (12.9 %) 234 (44.2 %) 200 (37.8 %) 3 3.20 0.77 0.60
PAM13-I 6 5 (0.9 %) 4 (0.8 %) 14 (2.6 %) 44 (8.3 %) 210 (39.7 %) 252 (47.6 %) 3 3.35 0.75 0.60
PAM13-I 7 5 (0.9 %) 7 (1.3 %) 17 (3.2 %) 42 (7.9 %) 196 (37.1 %) 262 (49.5 %) 4 3.36 0.77 0.55
PAM13-I 8 11 (2.1 %) 8 (1.5 %) 15 (2.8 %) 79 (14.9 %) 225 (42.5 %) 191 (36.1 %) 3 3.16 0.79 0.55
PAM13-I 9 6 (1.1 %) 14 (2.6 %) 24 (4.5 %) 78 (14.7 %) 234 (44.2 %) 173 (32.7 %) 3 3.09 0.82 0.54
PAM13-I 10 8 (1.5 %) 9 (1.7 %) 15 (2.8 %) 43 (8.1 %) 244 (46.1 %) 210 (39.7 %) 3 3.27 0.74 0.58
PAM13-I 11 6 (1.1 %) 9 (1.7 %) 16 (3.0 %) 68 (12.9 %) 247 (46.7 %) 183 (34.6 %) 3 3.16 0.77 0.65
PAM13-I 12 6 (1.1 %) 4 (0.8 %) 21 (4.0 %) 107 (20.2 %) 245 (46.3 %) 146 (27.6 %) 3 2.99 0.81 0.66
PAM13-I 13 4 (0.8 %) 11 (2.1 %) 16 (3.0 %) 71 (13.4 %) 256 (48.4 %) 171 (32.3 %) 3 3.13 0.76 0.58
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Differential Item Functioning
DIF was assessed to reveal significant differences in the
interpretation of the items for demographic characteris-
tics (i.e., sex, age, education). The DIF test for sex
showed statistical differences between male and female
patients in the items interpretation (LR-value = 67.8,
df = 38. p = 0.002). Differences were more relevant for
the interpretation of items 7, 12 and 13, which were
slightly more difficult to endorse for female than male
subjects were.
The DIF was tested for two subgroups in age
(younger than 55 years and older than 55). The test
revealed significant differences in items’ interpretation
(LR-value = 108.0, df = 38. p < 0.001). In particular,
item 2,3,6,7 and 13 were more difficult to endorse for
the older age group.
Finally, the DIF was tested for education. Two sub-
groups were compared: the first, in which are col-
lapsed primary and middle school, and the second in
which are collapsed high school, graduate and post-
graduated. The test showed significant differences
(LR-value = 97.6, df = 38. p < 0.001). Item 1 and 4 were
more difficult to endorse for low education group.
Item 7 was more difficult to endorse for high education
group. In all cases, DIF was particularly relevant for the
third cut off value between the response options “Agree”
and “Totally Agree”, but generally it was not so relevant to
affect the validity of the instrument.
Discussion
This study assessed the psychometric properties of the
Italian translation of the original American PAM 13.
Reliability, validity and responsiveness are context-
specific attributes and an instrument that has demon-
strated satisfactory measurement properties in one
population is not necessarily appropriate for use in other
populations [46]. The validation of the PAM 13 into dif-
ferent languages, clinical populations and cultural set-
tings will enable the generalizability of the measure as
well as allowing comparisons between countries and the
evaluation of context-related health models.
PAM13-I works very well as a measure of activation
with all items having very good psychometric properties
and item difficulty calibrating very similar to the original
PAM 13.
We obtained a high response rate with low percentage
of missing values per item. This may minimize the risk
of selection bias. The sample size of 519 subjects was
sufficient for this validation study as a minimum of 300
respondents is recommended to replicate structural ana-
lyses [47]. The mean square statistics used in the Rasch
analysis are moderately insensitive of sample size for
polytomous data [48].
Findings showed a good internal consistency of the
Italian version of the PAM 13 (Chrombach’s alpha:
0.88) which is comparable to the German, Danish,
Korean and Dutch version of the instrument and
slightly higher than the internal consistency of the
Hebrew one (0.77). For the American and Norwegian
versions of the instrument, no Chrombach’s alpha was
published.
The frequencies of the response categories in our
study showed little use of the category “Strongly
Disagree” and a moderate frequency for “Disagree”. The
Table 3 PAM13-I item fit statistics
PAM13_I Item no. Location Threshold 1 Threshold 2 Threshold 3 SE Infit Value MSQa Outfit Value MSQb
PAM13-I 2 0.05 −1.10 −0.24 1.49 0.4 1.14 1.19
PAM13-I 1 0.25 −0.50 −0.12 1.37 0.3 1.22 1.32
PAM13-I 6 0.31 −0.52 −0.36 1.81 0.3 0.86 0.78
PAM13-I 3 0.31 −0.87 −0.36 2.16 0.3 1.00 1.15
PAM13-I 7 0.35 −0.24 −0.36 1.66 0.3 0.88 0.88
PAM13-I 4 0.36 −0.44 −0.34 1.86 0.3 0.84 0.90
PAM13-I 10 0.45 −0.41 −0.50 2.24 0.3 0.89 0.89
PAM13-I 5 0.52 −0.80 0.06 2.31 0.3 0.86 0.89
PAM13-I 8 0.53 −1.02 0.26 2.35 0.3 0.92 0.96
PAM13-I 11 0.60 −0.73 0.02 2.50 0.3 0.76 0.74
PAM13-I 13 0.66 −0.75 0.06 2.66 0.3 0.91 0.93
PAM13-I 9 0.81 −0.38 0.25 2.56 0.3 1.02 1.14
PAM13-I 12 0.88 −0.85 0.60 2.90 0.3 0.85 0.85
aInfit MSQ reflects the similarity of observed responses from model expected response. Being most sensitive when the item and respondent are close together on
the activation scale
bOutfit MSQ is reflects unexpected observations with respect to the respondent’s other responses. It is most sensitive when the item location on the scale is far
away from the person’s location on the scale
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categories “Agree” and “Strongly Agree” were used with
the highest frequency for all the items. This finding is
similar to the one obtained in the German and in the
Danish validation studies. The Dutch, Norwegian,
Korean and Hebrew validation study did not published
this data. The irregular use of response options in Italy,
Germany and Denmark could be interpreted as a lack of
fit of the response scale in the European patient
population.
The mean PAM13-I score (66.2) was higher than the
reported score in the original validation study of
Hibbard and colleagues (61.9) in the Dutch validation
study (61.3), in the Danish (64.2) and in the Norwegian
ones (51.93) . On the contrary, the mean PAM13-I score
was lower than the German (68.1) and the Hebrew ones
(70.7). This might be related to the different samples’
characteristics and to their heterogeneity in term of
diagnosis. For instance, the higher rate of activated pa-
tients in the Italian sample might be related to their
mean age (53 y.o.), lower than the mean age of the
German (67 y.o.), Danish (62 y.o.) and Dutch (59 y.o.)
patients. Furthermore, the higher rate of activated
patients in the Italian sample may be also due to the
type of diagnosis: the Italian sample included a wide
range of chronic conditions that are recognized to re-
quire very different care prescriptions ranging from
routine examination to strict medication-taking regi-
mens. Moreover the more easily accessibility of
healthcare services in Italy compared to the other
healthcare system implies that every citizen is fully
covered for basic health services: the gratuity of
healthcare services in Italy may make patients per-
ceive them as more easily accessible. The low cost of
healthcare in Italy, in other terms, may be considered
as an organizational and contextual facilitator of pa-
tients’ use of healthcare services and thus of their ac-
tivation in self-management, but this assumption need
further investigation.
Our results also points out that older patients reported
lower activation scores. This result confirms previous re-
search evidences that observed the lowest PAM scores
among older chronic patients [19, 25, 26]. This finding is
not surprising, since previous studies have revealed a
lower perceived self-efficacy in older patient compared
Fig. 1 Person-item map
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to a younger clinical population [17, 22]. As people
age they are exposed to an increasing variety of per-
sonal and social conditions that challenge their sense
of control and independence. The tendency for indi-
viduals with low perceived self-efficacy to engage in
fewer health-promoting behaviors becomes stronger
in older adults mainly because physical decline is
often viewed as an unalterable part of the aging
process [49]. Moreover, older patients have been
found to have lower health literacy [50], a factor that
can hinder the elderly perception of being successful
in self-care tasks. Evidence demonstrated that older
patients may be reluctant to seek help for their com-
plaints, they experience more difficulty in seeking and
obtaining information during medical interviews and
participate less in their medical consultations than
other patients, even though they often have multiple
health problems [51]. Moreover, age-related factors
might hinder the patient’s ability to feel autonomous
in his/her daily tasks [52] also for what concerns the
medication-taking, thus making them less akin to
consider themselves successful in adhere to medical
treatments at home. Finally, we can also hypothesize
a sort of “generation effect”: older people are more
used to a paternalistic healthcare system and they
could be less disposed to be active agents in their
healthcare.
PCA and Rasch analysis indicated a homogenous fac-
tor structure with all items loading on one factor, thus
confirming the unidimensionality of the PAM13-I ac-
cording to the American PAM 13 version. In particular,
PCA showed good correlation among items but the
explaining variance (41 %) is not so high thus suggesting
the possibility that other latent factors could be included
but not statistically significant. This finding is similar to
the explaining variance calculated in the German study
(40.9 %) and in the Norwegian one (37.94 %) thus sug-
gesting that additional factors explaining variance may
be considered. This hypothesis is also embraced by
studies carried on the neurological population [22, 31, 53].
The latter study performed a confirmatory factory
analysis and suggested a tri-factor solutions as the
optimal one. The fact that PAM may have a multiple
factors structure may open to a conceptual refine-
ment of the concept of activation. Particularly the
role of patients’ emotions and of their psycho-social
elaboration of the illness’ burden may result worthy
to be further explored, with relevant implications for
the clinical practice [15].
Furthermore, the Rasch analysis of the items showed
that the original difficulty ranking order of the items is
not confirmed, similarly to the German, Danish and
Dutch validations. The differences in the items order in-
dicate that in the Italian population some items resulted
easier or more difficult to respond to than the
American population. For example, item 6 was rated
as slightly easier than items 3, 4 and 5; and item 10
was rated as slightly easier than items 5, 8 and 9. On
the contrary, item 5 was rated as slightly more diffi-
cult than items 6, 7 and 10; and item 9 was rated as
slightly more difficult than items 10, 11, and 13. Since
German, Dutch, Netherlands and Danish validation
studies cannot confirm the original items order, this
appears to be related to European specificities in the
healthcare system and in the chronic populations ap-
proach to self-care. Particularly, comparing our find-
ings with the other European validation studies, we
can envisage some similarities. For example, item 5
resulted more difficult in comparison to the original
order of the American version also in the Danish
sample; items 12 and 13 were rated as the most diffi-
cult items among Italian, Dutch and German popula-
tions consistently with the American one, although in
a slightly different order.
Furthermore, differences in the items ranking order
between European and American versions appeared as
less significant than those highlighted for the Korean
validation study, which deeply revised the original
American items’ order. This may be due at least partially
to the different socio-cultural approach to lifestyles and
health management connected respectively to individual-
istic or collectivistic tendencies [54].
It is also interesting to note some differential items
functioning according to gender, age groups and educa-
tion. According to the results of the DIF test, items 2, 3,
6, 7 and 13 resulted to be more difficult to be endorsed
by the subgroup of older patients. This finding is coher-
ent with evidences emerging from the German, Korean
and Danish validation studies, which envisaged some dif-
ferences in the DIF analysis per age related sub-groups.
Furthermore, items 7, 12 and 13 resulted to be more
difficult to be endorsed by the female subgroup. This
finding is partially coherent with those achieved in the
German validation study, which registered some differ-
ences in the DIF analysis per gender group. Finally items
1 and 4 resulted to be more difficult to be endorsed by
the lower educated group while the item 7 resulted to be
more difficult ot be endorsed by the higher educated
group. This findings are in some extent consistent with
those achieved in the Danish validation study, which en-
visaged some differences in the DIF analysis per educa-
tion groups. The Dutch, Norwegian and the Hebrew
validation study did not performed the DIF analysis. The
presence of DIF may suggest a not fully functionality of
the scale items in the PAM13-I, particularly for the item
7 (“I am confident that I can follow through on medical
treatments I need to do at home”) and 13 (“I am
confident that I can maintain lifestyle changes like diet
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and exercise even during times of stress”) across the con-
sidered subgroups of subjects. However, since all the other
psychometric properties of the PAM13-I has been demon-
strated to be acceptable we consider that the DIF results
do not compromise the validity of the instrument.
Concerning this study’s limitations, the rather het-
erogeneous group of patients may be regarded as a
weakness. However, when assessing scale properties,
the use of a population representing many levels of
activation could be considered an advantage. Further-
more, although the sample included in our study is
not a stratified and fully representative of the Italian
chronic population, it was randomly selected in order
to guarantee its probabilistic feature. We used it only
to explore the relationships of the variables under
analysis (i.e. for associative purposes and not for a de-
scriptive estimation of their dimensions): based on
these considerations full representativeness is not ne-
cessarily required [55, 56]. However, even though
population parameters were not the study aim, the
quality of the study might be negatively affected and
also create errors in the current analysis, thus further
research is warranted to confirm the validation of the
PAM13-I. Limitations of this study relate to the
cross-sectional design that does not allow for calcula-
tion of test-retest reliability because we only have one
measurement point. Furthermore, similarly to the
Korean, Danish and the Norwegian validation studies
of PAM 13, our study did not include correlation
measures to test construct and criteria validity. How-
ever construct and criteria validity were previously
tested in the first development and validation process
of the America version of PAM 13, by well demon-
strating the validity of the instrument [17].
Conclusion
It can be concluded that the aims of the study were
achieved, especially considering that the validity and reli-
ability of the PAM13-I were measured through rigorous
and extensive methodological analysis. As it allows the
adaptation of instruments to the specificities of health-
care systems and care process that are culturally rooted,
the importance of conducting cross-cultural validation
studies should be emphasized. Moreover, the psychomet-
ric findings presented provide more credibility to its use,
both as a methodological resource in research and as a
screening tool in a wide variety of clinical context.
Assessing patients’ activation level could be crucial in
order to train health practitioners in effectively commu-
nicating with their patients and to tailor health messages
and self-management goals, so relevant when treating
chronic diseases [34, 57, 58]. Compared to the regular
clinical approach, an intervention with tailored messages
has proven to lead to greater improvement in the
patients’ clinical markers, such as enhanced adherence
to prescribed medication regimens, shorter hospitaliza-
tions and limited use of the emergency department [59].
Furthermore, patient activation has proven to be incre-
mental [60, 61]. This makes it even more relevant since it
can not only be used for categorizing patients and con-
sumers and tailoring support and education, but also for
actual improvement of consumer engagement with re-
spect to their health and health care, both on an individual
and on a population level [62–64]. Recognizing that
factors at different levels of complexities might affect
patient activations, future research should be devoted
to enrich the validity of the PAM 13. This could be
valuable in order to conduct a more comprehensive as-
sessment of the individual, relational and organizational
aspects occurring to foster patient engagement in the
care process, as well as to assess clinicians’ communica-
tive and relational practice aimed at sustaining patient
activation [15, 65, 66].
Appendix
Table 4 Original PAM13 Questions
PAM13 Item no. Item
1 When all is said and done. I am the person who is
responsible for managing my health condition
2 Taking an active role in my own health care is the
most important factor in determining my health and
ability to function
3 I am confident that I can take actions that will help
prevent or minimize some symptoms or problems
associated with my health condition
4 I know what each of my prescribed medications do
5 I am confident that I can tell when I need to go get
medical care and when I can handle a health
problem myself
6 I am confident I can tell my health care provider
concerns I have even when he or she does not ask
7 I am confident that I can follow through on medical
treatments I need to do at home
8 I understand the nature and causes of my health
condition(s)
9 I know the different medical treatment options
available for my health condition
10 I have been able to maintain the lifestyle changes
for my health that I have made
11 I know how to prevent further problems with my
health condition
12 I am confident I can figure out solutions when
new situations or problems arise with my
health condition
13 I am confident that I can maintain lifestyle changes
like diet and exercise even during times of stress
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